Hebrew, English
Head of the International Department
Gary is a partner in Lipa Meir and Head of the International Department. Gary is instructed by a variety of clients across a full range of activities in corporate law, with a focus on cross-border M&A and providing strategic legal advice to Israeli and international clients alike.
Over the years, and through his in-depth understanding of the intricacies of international law, Gary has gained the reputation of a leading attorney in the international commercial field. Gary has vast experience in all forms of commercial law, specializing in myriad niche areas. Gary's expertise enables him to provide tailor-made legal solutions to his diverse client portfolio, ranging from hi-tech start-ups, automotive industry companies, retail businesses, health organizations (public and private alike), cannabis farms and more. Gary advises his clients in a broad variety of legal matters, covering cross-border M&A transactions, agreements with OEM's, joint ventures, financing agreements and assisting Israeli companies in setting up suitable corporate structures for their international activities. With many of his clients, Gary provides innovative legal multidisciplinary advice. For example: incorporating expertise in privacy issues related to healthcare and life sciences with international commercial agreements, all in a seamlessly professional and highly responsive manner. These complex transactions, as well as the vast experience held by the attorneys in the department, are the key factors to the high growth rate the department is experiencing in recent years in an ever-increasing competitive market.
Notably, Gary advises Israel's largest Health Maintenance Organization ("HMO"), Clalit Health Services, which is also the second largest HMO worldwide, with approximately 35,000 employees, some 4.5 million insureds and which operates 14 hospitals and hundreds of clinics nationwide. Such advice encompasses a multitude of disciplines ranging from "traditional" corporate advice to administrative and regulatory issues raised by health care providers and insureds, including public health, health-care administration, supplementary health insurance, medical equipment and devises, utilization of big-data and health legislation and regulation.
Gary is recommended by Legal500 in the fields of Commercial, Corporate and M&A and his instruction by Clalit Health Services is also noted.
Education
Brunel University London, UK (LL.B, with Honors, 1995)
Certification
Israel Bar Association, 1997
Languages
News & Publications
12.09.21
E-signature World Guide
https://ally-law.com/
As an international organization comprising more than 70 law firms worldwide, Ally Law has worked with its member firms to put together a valuable guide on the regulation of e-signatures and digital transactions around the world. Gary Copelovitz, Head of our International Department, provided the relevant information on the applicable regulation in Israel, which you […]
20.05.21
Lipa Meir & Co. is hugely proud and would like to congratulate our partner and Head of International Department, Gary Copelovitz, who has won “Corporate Lawyer of the Year”
Lipa Meir & Co. is hugely proud and would like to congratulate our partner and Head of International Department, Gary Copelovitz, who has won “Corporate Lawyer of the Year” at this year’s LMG’s Life Sciences Legal Awards in Europe. LMG Life Sciences Awards Researcher John Harrison said of Gary’s win: “He is well-known for his […]
11.04.21
LMG Life Sciences
Awards 2021
Lipa Meir is shortlisted in the LMG Life Sciences Awards 2021 for Israel’s Life Sciences Law Firm of the Year, as well as in the category of Corporate Law Firm of the Year (Europe)! In addition, Head of our International Department, Gary Copelovitz, is shortlisted for Corporate Lawyer of the Year (Europe). Part of the seasoned […]
19.10.20
Mileutis raises $20 million to reduce antibiotic use in cows
calcalistech
Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment […]
19.10.20
Israeli animal health co Mileutis raises $20m
Globes
Mileutis is in advanced stages of development of an innovative product which addresses bovine mastitis, the main concern in the dairy industry. Israeli animal health company Mileutis Ltd. has received a $20 million investment from US life sciences and healthcare investor NovaQuest Capital Management LLC, as part of a product financing agreement. Ness Ziona-based Mileutis […]
21.07.20
FutureMed 2020 – Online Conference
FutureMed 2020
The first wave of the CoronaVirus pandemic has hit every sphere of public and private life. Different governments have presented different approaches, all of which have been asked to plan and adopt health management and new regulations on the move, while no one has an unequivocal answer to the key question: What is the right […]
16.04.20
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
18.09.19
Business Judgment Rule – Dividend Distribution
Newsletter
In a recent ruling by the Judge of the Economic Department of the Tel Aviv District Court, Ruth Ronen, a guideline was given in relation to the application of the Business Judgment Rule doctrine to decisions taken by the officers of a company in the context of dividend distribution. In the case, an application to […]
13.06.19
The Business Judgement Rule in Derivative Actions
Newsletter
In a recent judgment of the Israeli Supreme Court, a significant precedent was handed down by Judge Yoram Danziger, setting out that the Business Judgment Rule applies to a company’s board of directors when it is deciding whether to file a derivative action. The case brought before the Supreme Court dealt with a dispute between […]
06.12.18
China’s Newater to Acquire Water Purification Company AMS for $13.5 Million
Calcalist
We are proud to announce the acquisition of the Israeli start-up, AMS Technologies, by Newater, a Chinese public company traded on the NASDAQ. Both companies are engaged in the field of wastewater technologies. AMS was represented by Adv. Gary Copelovitz, Danit Rimon and Gad Keren of our firm. For the full article in Calcalist, click here
